| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 686498 | (3S)-3-(2,3,4,6-Tetra-O-pivaloyl-.beta.-D-glucopyranosyloxy)-1-butanol | 0.0103070729572494 | 0.052489496 |
| NSC 753907 | Null | 0.0103070729572494 | 0.050976539 |
| NSC 754073 | 7-(2-methoxybenzyl)-6-phenyl-5,7-dihydro-4H-isoxazolo[5,4-e]isoindole | 0.0103070729572494 | 0.11224777 |
| NSC 762148 | N-(4-{2-[(1R,6R,11aS,13S,14aR)-1,13-dihydroxy-4-oxo-1,6,7,8,9,11a,12,13,14,14a-decahydro-4H-cyclopenta[f]oxacyclotridecin-6-yl]ethyl}phenyl)-N'-(3',6'-dihydroxy-3-oxo-3H-spiro[2-benzofuran-1,9'-xanth | 0.0103070729572494 | -0.099077346 |
| NSC 606699 | Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt | 0.0112651116880208 | 0.29159585 |
| NSC 643248 | 23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2 | 0.0112651116880208 | 0.32150386 |
| NSC 679024 | 1,8-Naphthyridin-4(1H)-one, 2-(4-fluorophenyl)-5-methyl- | 0.0112651116880208 | -0.16439112 |
| NSC 720134 | Null | 0.0112651116880208 | -0.20104909 |
| NSC 732492 | Null | 0.0112651116880208 | 0.10731399 |
| NSC 740357 | Null | 0.0112651116880208 | 0.31945639 |